Medical Xpress June 23, 2021
University of Leeds

A study involving virtual rather than real patients was as effective as traditional clinical trials in evaluating a medical device used to treat brain aneurysms, according to new research.

The findings are proof of concept for what are called in-silico trials, where instead of recruiting people to a real-life clinical trial, researchers build digital simulations of patient groups, loosely akin to the way virtual populations are built in The Sims computer game.

In-silico trials could revolutionize the way clinical trials are conducted, reducing the time and costs of getting new medical devices and medicines developed, while reducing human and animal harm in testing.

The virtual patient populations are developed from clinical databases to reflect age, sex and ethnicity but they...

Today's Sponsors

ZeOmega
Holon
Transcarent

Today's Sponsors

Crossover Health
Qure4u

Today's Sponsor

Institute for Healthcare Improvement

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Survey / Study, Trends
Researchers find gaps in clinical trial data sharing
6 ways to protect your pharma company from cyberattacks
Most Older Patients Can Manage Drugs After Hospital Discharge, Study Finds
Vizient’s Outlook Report Is a Mixed Bag: Projected 2022 Drug Spend, White Bagging, Insulin Competition and COVID-19 Treatment. It’s All in There.
Anthem, Humana join hedge fund to launch PBM